HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mudi Misgav Selected Research

Mudi Misgav Research Topics

Disease

14Hemorrhage
02/2022 - 07/2004
10Hemophilia A (Haemophilia)
08/2023 - 01/2017
3Thrombosis (Thrombus)
05/2023 - 07/2018
3Thrombocytopenia (Thrombopenia)
01/2022 - 07/2004
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2023 - 05/2023
2Hypersensitivity (Allergy)
01/2023 - 12/2018
2Hemarthrosis
01/2021 - 01/2017
2Wounds and Injuries (Trauma)
10/2020 - 02/2011
2Thrombasthenia (Glanzmann Thrombasthenia)
09/2018 - 01/2012
2Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
07/2018 - 05/2011
1Cutaneous Leukocytoclastic Vasculitis (Hypersensitivity Angiitis)
01/2023
1Exanthema (Rash)
01/2023
1Necrosis
01/2023
1IgA Vasculitis (Purpura, Schoenlein Henoch)
01/2023
1Abdominal Pain (Pain, Abdominal)
01/2023
1Purpura Fulminans
01/2023
1Pulmonary Embolism
01/2022
1Venous Thromboembolism
01/2022
1Metrorrhagia (Spotting)
09/2021
1Joint Diseases (Joint Disease)
01/2021
1Type 3 von Willebrand Disease
01/2021
1von Willebrand Diseases (von Willebrand's Disease)
01/2021
1Hemophilia B (Haemophilia B)
12/2018
1Autoimmune Diseases (Autoimmune Disease)
01/2012
1Disseminated Intravascular Coagulation
02/2011
1Acidosis
02/2011
1Hypotension (Low Blood Pressure)
02/2011
1Hypothermia
02/2011
1Stroke (Strokes)
01/2007
1Atrial Fibrillation
01/2007
1Intracranial Hemorrhages (Intracranial Hemorrhage)
11/2006
1Venous Thrombosis (Deep-Vein Thrombosis)
07/2004

Drug/Important Bio-Agent (IBA)

6emicizumabIBA
08/2023 - 10/2020
6Hemostatics (Antihemorrhagics)IBA
02/2022 - 02/2011
4Factor VIII (Coagulation Factor VIII)IBA
08/2023 - 06/2017
3ThrombinFDA Link
03/2021 - 02/2011
3Fibrinogen (Factor I)FDA Link
01/2012 - 02/2011
3AnticoagulantsIBA
01/2007 - 07/2004
2Inosine Triphosphate (ITP)IBA
07/2018 - 05/2011
2anti-inhibitor coagulant complexIBA
01/2018 - 01/2017
2ChitosanIBA
05/2017 - 03/2014
2recombinant FVIIa (rFVIIa)FDA Link
02/2011 - 11/2006
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2023
1Immunoglobulin A (IgA)IBA
01/2023
1Naproxen (Naprosyn)FDA LinkGeneric
01/2023
1Protein CIBA
01/2023
1recombinant factor VIII N8IBA
02/2022
1Cardiolipins (Cardiolipin)IBA
01/2022
1Immunoglobulin G (IgG)IBA
01/2022
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2022
1AntibodiesIBA
01/2022
1A-factor (Streptomyces)IBA
09/2021
1prothrombin complex concentrates (PPSB)IBA
12/2018
1Factor IX (Coagulation Factor IX)FDA LinkGeneric
12/2018
1Heparin (Liquaemin)FDA LinkGeneric
06/2017
1Protamines (Protamine Sulfate)FDA Link
06/2017
1Factor XIII (Coagulation Factor XIII)IBA
01/2012
1von Willebrand FactorIBA
05/2011
1Blood Coagulation Factors (Coagulation Factor)IBA
02/2011
1Tranexamic Acid (AMCA)FDA Link
02/2011
1Starch (Cornstarch)IBA
02/2011
1FibrinIBA
02/2011
1Dacarbazine (DIC)FDA LinkGeneric
02/2011
1Warfarin (Coumadin)FDA LinkGeneric
01/2007
1Enoxaparin (Lovenox)FDA LinkGeneric
07/2004

Therapy/Procedure

8Therapeutics
09/2021 - 01/2007
2Operative Surgical Procedures
08/2023 - 09/2018
2Drug Therapy (Chemotherapy)
05/2023 - 07/2004
2Minor Surgical Procedures (Minor Surgery)
12/2018 - 01/2017
2Platelet Transfusion (Blood Platelet Transfusions)
09/2018 - 01/2018
1Induction Chemotherapy
10/2023
1Surgical Amputation (Amputations)
01/2023
1Injections
05/2019
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
06/2017
1Punctures
05/2017
1Renal Dialysis (Hemodialysis)
05/2017
1Resuscitation
02/2011
1Catheters
07/2004